Lior Susan - 10 Oct 2025 Form 4 Insider Report for Owlet, Inc. (OWLT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Oct 2025, 18:51:08 UTC
Prior SEC filing
22 Aug 2024
Next SEC filing
13 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lior Susan

Key filing fact

Lior Susan filed Form 4 for Owlet, Inc. (OWLT) on 15 Oct 2025.

Key facts

  • This page summarizes Lior Susan's Form 4 filing for Owlet, Inc. (OWLT).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 15 Oct 2025, 18:51.

Change

  • Previous filing in this sequence was filed on 22 Aug 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001832895 Primary reporting owner

Susan Lior

Relationship
Director, 10%+ Owner
Address
C/O OWLET, INC., 3300 NORTH ASHTON BOULEVARD, SUITE 300, LEHI
Signature
/s/ Lior Susan
Signature date
15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OWLT transaction

Common Stock

Award

Transaction value
Shares
+3,898,906
Change %
+221%
Price
Shares after
5,665,669
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F1, F2
OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
968,694
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F3
OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,066,472
Date
10 Oct 2025
Ownership
See footnote
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OWLT transaction Derivative

Series A Warrants (Right to Purchase Shares of Common Stock)

Disposed to Issuer

Transaction value
Shares
-5,300,291
Change %
-100%
Price
Shares after
0
Date
10 Oct 2025
Ownership
See footnote
Underlying class
Class A Common Stock
Underlying amount
5,300,291
Exercise price
Footnotes
F1, F2
OWLT transaction Derivative

Series B Warrants (Right to Purchase Shares of Common Stock)

Disposed to Issuer

Transaction value
Shares
-1,166,935
Change %
-100%
Price
Shares after
0
Date
10 Oct 2025
Ownership
See footnote
Underlying class
Class A Common Stock
Underlying amount
1,166,935
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder.

Footnote F2

The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any.

Footnote F3

The securities are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.

Footnote F4

The securities are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .